← Leaderboards
Moo J Cho
University Of North Carolina Chapel Hill
$2,181,031
Attributed
$2,181,031
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $302.4K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,181,031 · 3
By mechanism
R01$1,491,998 · 1
R21$689,033 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Pierre Morell$2,381,537
- Robert E. Johnston$11,943,669
- Mark T Heise$26,876,746
- Mitsuo Yamauchi$3,335,097
- James E Faber$12,717,060
Others in their field
Top investigators on “Endocytosis”
- David G. Drubin · University Of California Berkeley$25,569,332
- Sandra L. Schmid · Scripps Research Institute$20,743,332
- Mark E. Von Zastrow · University Of California, San Francisco$19,395,532
- Alexander D Sorkin · University Of Pittsburgh At Pittsburgh$18,987,111
- Bruce L Goode · Brandeis University$17,913,101
- Andrew P. Kowalczyk · Emory University$15,366,538
Research focus
EndocytosisCrosslinkCancer TherapyAbbreviationsCancer ImmunotherapyAntibodiesAntigensAntigen-Antibody ComplexAntithymoglobulinAnimal Model2,4-DinitrophenolArecaceaeAsthmaAvidityAzidesA MouseBaseBinding (Molecular Function)BiodistributionBloodBlood CirculationBone MarrowAnimalsCancer Patient
Grant awards (9)
Systemic Delivery of CpG Oligonucleotides$292,871
R01 · FY2012 · CA · contact PI
Systemic Delivery of CpG Oligonucleotides$293,017
R01 · FY2011 · CA · contact PI
Systemic Delivery of CpG Oligonucleotides$302,226
R01 · FY2010 · CA · contact PI
Systemic Delivery of CpG Oligonucleotides$302,368
R01 · FY2009 · CA · contact PI
Systemic Delivery of CpG Oligonucleotides$301,516
R01 · FY2008 · CA · contact PI
pH- SENSITIVE BIS-DETERGENTS FOR MACROMOLECULAR DELIVERY$179,729
R21 · FY2005 · GM
pH- SENSITIVE BIS-DETERGENTS FOR MACROMOLECULAR DELIVERY$202,429
R21 · FY2004 · GM
TARGETING ENDOGENOUS ANTIBODIES TO OVARIAN CARCINOMA$147,750
R21 · FY2003 · CA
TARGETING ENDOGENOUS ANTIBODIES TO OVARIAN CARCINOMA$159,125
R21 · FY2002 · CA